224 related articles for article (PubMed ID: 30280193)
1. Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review).
Ma C; Liu S; Zhang S; Xu T; Yu X; Gao Y; Zhai C; Li C; Lei C; Fan S; Chen Y; Tian H; Wang Q; Cheng F; Wang X
Int J Mol Med; 2018 Dec; 42(6):2979-2990. PubMed ID: 30280193
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome: a promising target in ischemic stroke.
Gao L; Dong Q; Song Z; Shen F; Shi J; Li Y
Inflamm Res; 2017 Jan; 66(1):17-24. PubMed ID: 27576327
[TBL] [Abstract][Full Text] [Related]
3. Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke.
Fann DY; Lim YA; Cheng YL; Lok KZ; Chunduri P; Baik SH; Drummond GR; Dheen ST; Sobey CG; Jo DG; Chen CL; Arumugam TV
Mol Neurobiol; 2018 Feb; 55(2):1082-1096. PubMed ID: 28092085
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling.
Qiu J; Wang M; Zhang J; Cai Q; Lu D; Li Y; Dong Y; Zhao T; Chen H
Int Immunopharmacol; 2016 Nov; 40():492-500. PubMed ID: 27769021
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes.
Hong P; Gu RN; Li FX; Xiong XX; Liang WB; You ZJ; Zhang HF
J Neuroinflammation; 2019 Jun; 16(1):121. PubMed ID: 31174550
[TBL] [Abstract][Full Text] [Related]
6. The NLRP3 Inflammasome: An Important Driver of Neuroinflammation in Hemorrhagic Stroke.
Yang SJ; Shao GF; Chen JL; Gong J
Cell Mol Neurobiol; 2018 Apr; 38(3):595-603. PubMed ID: 28752408
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome contributes to neurovascular unit damage in stroke.
Sun J; Chi L; He Z; Gao Y; Gao Y; Huang Y; Nan G
J Drug Target; 2019 Sep; 27(8):866-875. PubMed ID: 30601069
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders.
Zhou K; Shi L; Wang Y; Chen S; Zhang J
J Immunol Res; 2016; 2016():9238290. PubMed ID: 27652274
[TBL] [Abstract][Full Text] [Related]
10. Minocycline Suppresses NLRP3 Inflammasome Activation in Experimental Ischemic Stroke.
Lu Y; Xiao G; Luo W
Neuroimmunomodulation; 2016; 23(4):230-238. PubMed ID: 27846628
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome activation after ischemic stroke.
Han PP; Han Y; Shen XY; Gao ZK; Bi X
Behav Brain Res; 2023 Aug; 452():114578. PubMed ID: 37437697
[TBL] [Abstract][Full Text] [Related]
12. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
Kim JK; Jin HS; Suh HW; Jo EK
Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
[TBL] [Abstract][Full Text] [Related]
13. Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse.
Ye X; Shen T; Hu J; Zhang L; Zhang Y; Bao L; Cui C; Jin G; Zan K; Zhang Z; Yang X; Shi H; Zu J; Yu M; Song C; Wang Y; Qi S; Cui G
Exp Neurol; 2017 Jun; 292():46-55. PubMed ID: 28274860
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
16. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
17. Irisin protects against neuronal injury induced by oxygen-glucose deprivation in part depends on the inhibition of ROS-NLRP3 inflammatory signaling pathway.
Peng J; Deng X; Huang W; Yu JH; Wang JX; Wang JP; Yang SB; Liu X; Wang L; Zhang Y; Zhou XY; Yang H; He YZ; Xu FY
Mol Immunol; 2017 Nov; 91():185-194. PubMed ID: 28961497
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms regulating NLRP3 inflammasome activation.
Jo EK; Kim JK; Shin DM; Sasakawa C
Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
[TBL] [Abstract][Full Text] [Related]
19. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
20. Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes.
Gong T; Yang Y; Jin T; Jiang W; Zhou R
Trends Immunol; 2018 May; 39(5):393-406. PubMed ID: 29452983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
